These are specialised fields and I believe the opinion of the writer is based on what has been reported in the medical journals. The upcoming conference will provide the findings which could possibly prove the benefits of MSB's technology that stem cells can either in conjunction with LVADs or on its own improve the quality of life of patients at end stage heart failure. End stage heart failure are cases where all other treatments have failed and death is imminent and currently LVHD's are the only avenue for prolonging the life of the patients. The findings presented at this conference will be most interesting and being a late-breaking presentation would imply its ground breaking. Thats my view
MSB chart, page-893
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.005(0.43%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $2.167M | 1.851M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 42017 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 28520 | 16 |
View Market Depth
| Last trade - 12.57pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |